| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2394856C Enzyme treatment for infection |
| 05/06/2011 | CA2699024A1 Methods of immunizing pregnant heifers at three months of gestation |
| 05/05/2011 | WO2011053917A2 Gastroretentive oral high dose zinc preparations |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011053003A2 Gastric-retentive sustained release formulation containing pregabalin, polyethyleneoxide and pva-peg graft copolymer |
| 05/05/2011 | WO2011052799A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | WO2011052759A1 Novel nitroxyl radical compound and process for production thereof |
| 05/05/2011 | WO2011052753A1 Antibody binding to mansc1 protein and having anticancer activity |
| 05/05/2011 | WO2011052638A1 Process for production of cytokine-induced killer cells |
| 05/05/2011 | WO2011052523A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | WO2011051900A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
| 05/05/2011 | WO2011051760A1 Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria |
| 05/05/2011 | WO2011051742A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
| 05/05/2011 | WO2011050742A1 New crystalline forms of agomelatine and preparation methods thereof |
| 05/05/2011 | WO2011050709A1 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa |
| 05/05/2011 | WO2011050397A1 Novel enteric combination therapy |
| 05/05/2011 | WO2011037349A8 Target specific drug delivery system, target non-specific long-acting drug delivery system and method of controlling target specificity thereof |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105590 Compositions And Methods For Inhibiting Expression Of Anti-Apoptotic Genes |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105571 Opioid Receptor Antagonists |
| 05/05/2011 | US20110105563 Il-8 receptor antagonists |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105556 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105550 Forms of rifaximin and uses thereof |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105524 Cysteine protease inhibitors |
| 05/05/2011 | US20110105510 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105451 Screening of a Novel Hepatic Syndrome and its Uses |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105394 Amylin Derivatives |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 05/05/2011 | US20110104285 Process for the manufacture of a pharmaceutical product |
| 05/05/2011 | US20110104282 New Therapy of Treatment of the Irritable Bowel Syndrome |
| 05/05/2011 | US20110104269 Compositions for the oral delivery of corticosteroids |
| 05/05/2011 | US20110104264 Gastric acid secretion inhibiting composition |
| 05/05/2011 | US20110104239 Probiotic chewing gum method of manufacture |
| 05/05/2011 | US20110104231 Bioceramic and biopolymer composite |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104179 Protease inhibitory peptides |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104126 Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | CA2779518A1 Gastroretentive oral high dose zinc preparations |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2778895A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | CA2778890A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | CA2778884A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
| 05/05/2011 | CA2778181A1 Novel enteric combination therapy |
| 05/05/2011 | CA2777033A1 Spirolactam derivatives and uses of same |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316473A1 Use of calcitonin in osteoarthritis |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315582A2 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP2048145B9 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 05/04/2011 | EP1607395B1 Process for the preparation of amorphous rabeprazole sodium salt |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1404363B1 Adjuvant composition for mucosal and injection delivered vaccines |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1306429B1 Method of screening ptp zeta activity promoter or inhibitor |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | CN201814844U Fumigating belt for a plurality of pulse |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046624A Tetrahydronaphthyridines and aza derivatives thereof as histamine H3 receptor antagonists |
| 05/04/2011 | CN102046622A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 05/04/2011 | CN102046194A Drug, dental material, and screening method |